SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan
NEOG 6.050-3.9%Nov 4 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kramer who wrote ()11/10/1998 9:52:00 PM
From: Kramer   of 441
 
From Zacks: Research Abstract - Neogen Corp (Nasdaq:NEOG)
Roney Capital Markets

Roney Capital Markets issued a Company Report on October 23, 1998 for Neogen Corporation.

On October 23, 1998 Roney Capital Markets analyst Lynn Malkes issued a 5 page Company Report on Neogen Corporation. Report highlights: 'The company reported fiscal first quarter EPS of $0.13, a 29% increase over last year's first quarter. The company had an interest in expanding its food safety portfolio as the FDA continued to enforce its seafood regulations that went into effect January, 1998. A BUY rating was maintained with a price target of $12 per share.'

Report No.: N0110468

The full text of this and over 30,000 other reports are available for purchase from Zacks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext